Annual CFF
$10.92 M
+$10.92 M+100.00%
December 31, 2023
Summary
- As of February 8, 2025, VVOS annual cash flow from financing activities is $10.92 million, with the most recent change of +$10.92 million (+100.00%) on December 31, 2023.
- During the last 3 years, VVOS annual CFF has fallen by -$12.61 million (-53.59%).
- VVOS annual CFF is now -54.80% below its all-time high of $24.17 million, reached on December 31, 2021.
Performance
VVOS Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$3.79 M
-$3.61 M-48.82%
September 30, 2024
Summary
- As of February 8, 2025, VVOS quarterly cash flow from financing activities is $3.79 million, with the most recent change of -$3.61 million (-48.82%) on September 30, 2024.
- Over the past year, VVOS quarterly CFF has stayed the same.
- VVOS quarterly CFF is now -85.07% below its all-time high of $25.37 million, reached on June 30, 2021.
Performance
VVOS Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$18.39 M
+$3.79 M+25.93%
September 30, 2024
Summary
- As of February 8, 2025, VVOS TTM cash flow from financing activities is $18.39 million, with the most recent change of +$3.79 million (+25.93%) on September 30, 2024.
- Over the past year, VVOS TTM CFF has stayed the same.
- VVOS TTM CFF is now -61.31% below its all-time high of $47.53 million, reached on June 30, 2021.
Performance
VVOS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
VVOS Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.0% | 0.0% | 0.0% |
| 3 y3 years | -53.6% | +422.6% | -58.7% |
| 5 y5 years | +107.9% | +10000.0% | -21.5% |
VVOS Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -54.8% | -100.0% | -48.8% | -100.0% | -24.0% | +1666.4% |
| 5 y | 5-year | -54.8% | -100.0% | -85.1% | +422.6% | -61.3% | +1666.4% |
| alltime | all time | -54.8% | -100.0% | -85.1% | +422.6% | -61.3% | +1666.4% |
Vivos Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $3.79 M(-48.8%) | $18.39 M(+25.9%) |
| Jun 2024 | - | $7.40 M(+103.6%) | $14.60 M(+102.7%) |
| Mar 2024 | - | $3.63 M(+1.9%) | $7.20 M(-34.1%) |
| Dec 2023 | $10.92 M(>+9900.0%) | $3.57 M(>+9900.0%) | $10.92 M(+48.5%) |
| Sep 2023 | - | $0.00(0.0%) | $7.36 M(0.0%) |
| Jun 2023 | - | $0.00(-100.0%) | $7.36 M(0.0%) |
| Mar 2023 | - | $7.36 M(>+9900.0%) | $7.36 M(>+9900.0%) |
| Dec 2022 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2022 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Jun 2022 | - | $0.00(0.0%) | -$1.17 M(-104.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $0.00(0.0%) | $24.19 M(+0.1%) |
| Dec 2021 | $24.17 M(+2.7%) | $0.00(-100.0%) | $24.17 M(-45.7%) |
| Sep 2021 | - | -$1.17 M(-104.6%) | $44.54 M(-6.3%) |
| Jun 2021 | - | $25.37 M(<-9900.0%) | $47.53 M(+102.9%) |
| Mar 2021 | - | -$25.00 K(-100.1%) | $23.43 M(-0.4%) |
| Dec 2020 | $23.54 M(+426.7%) | $20.37 M(+1017.4%) | $23.54 M(+643.0%) |
| Sep 2020 | - | $1.82 M(+44.1%) | $3.17 M(+135.6%) |
| Jun 2020 | - | $1.27 M(+1491.6%) | $1.34 M(+1591.6%) |
| Mar 2020 | - | $79.50 K | $79.50 K |
| Dec 2019 | $4.47 M(-14.9%) | - | - |
| Dec 2018 | $5.25 M | - | - |
FAQ
- What is Vivos Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Vivos Therapeutics?
- What is Vivos Therapeutics annual CFF year-on-year change?
- What is Vivos Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Vivos Therapeutics?
- What is Vivos Therapeutics quarterly CFF year-on-year change?
- What is Vivos Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Vivos Therapeutics?
- What is Vivos Therapeutics TTM CFF year-on-year change?
What is Vivos Therapeutics annual cash flow from financing activities?
The current annual CFF of VVOS is $10.92 M
What is the all time high annual CFF for Vivos Therapeutics?
Vivos Therapeutics all-time high annual cash flow from financing activities is $24.17 M
What is Vivos Therapeutics annual CFF year-on-year change?
Over the past year, VVOS annual cash flow from financing activities has changed by +$10.92 M (+100.00%)
What is Vivos Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of VVOS is $3.79 M
What is the all time high quarterly CFF for Vivos Therapeutics?
Vivos Therapeutics all-time high quarterly cash flow from financing activities is $25.37 M
What is Vivos Therapeutics quarterly CFF year-on-year change?
Over the past year, VVOS quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Vivos Therapeutics TTM cash flow from financing activities?
The current TTM CFF of VVOS is $18.39 M
What is the all time high TTM CFF for Vivos Therapeutics?
Vivos Therapeutics all-time high TTM cash flow from financing activities is $47.53 M
What is Vivos Therapeutics TTM CFF year-on-year change?
Over the past year, VVOS TTM cash flow from financing activities has changed by $0.00 (0.00%)